ConforMIS Inc
Funding rounds
3 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Oct 2011 | $83 M | No. 3 | $50 to $250 million | equity, options | SEC | |
| Jun 2011 | $97 M | No. 2 | $50 to $250 million | equity, options | SEC | |
| Dec 2009 | $2 M | Issued in a merger or acquisition | $2 to $10 million | equity | SEC | |
| Jun 2008 | $75 M | No. 1 | $50 to $250 million | equity, debt, options | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
ConforMIS Inc chose not to state its revenue in its newest notice of a funding round (Aug 2014).
SEC Form D · Aug 2014
The industry group it chose in its notices: Other Health Care.
SEC Form D · Jul 2013
That is all the official record says: ConforMIS Inc has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
16 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| Abu Dhabi Investment Authority | Fund or asset manager | not stated | not stated | Held Series E-1 and E-2 preferred stock, 10% owner, director (Form 3, 2015) | SEC Form 3 |
| Abu Dhabi Investment Council | Fund or asset manager | not stated | not stated | Held Series E-1 and E-2 preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
| aeris CAPITAL Archer L.P. | Fund or asset manager | not stated | not stated | Held Series D, E-1 and E-2 preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
| AGC Equity Partners Investment Management Ltd | Private equity | not stated | not stated | Held Series E-1 and E-2 preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
| AGC Equity Partners Special Opportunities Fund I, L.P. | Private equity | not stated | not stated | Held Series E-1 and E-2 preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
| AGC Equity Partners Special Opportunities General Partner 1 Ltd | Private equity | not stated | not stated | Held Series E-1 and E-2 preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
| Biomedical Sciences Investment Fund Pte Ltd. | Fund or asset manager | not stated | not stated | Held Series D preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
| Centurion Asia Private Equity Fund | Private equity | not stated | not stated | Held Series D, E-1 and E-2 preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
| EDB Investments Pte Ltd. | Fund or asset manager | not stated | not stated | Held Series D preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
| Hofung Holdings Ltd | Company | not stated | not stated | Held Series A, B, C, D and E-1 preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
| NewtrAx LLC | Other | not stated | not stated | Held Series E-1 and E-2 preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
| Ped-Cnfrms-C, LLC | Other | not stated | not stated | Held Series C preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
| SGR Sagittarius Holding AG | Company | not stated | not stated | Held Series B, C and D preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
| Stanhope Investments | Fund or asset manager | not stated | not stated | Held Series E-1 and E-2 preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
| Tasik Temenggor Investments (Cayman Islands) Ltd | Fund or asset manager | not stated | not stated | Held Series E-1 and E-2 preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
| Veron International LTD | Company | not stated | not stated | Held Series B, C and D preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 91 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| David Christopher Cerveny | Executive officer | Aug 2014 |
| Paul Weiner | Executive officer | Aug 2014 |
| Philipp Lang | Executive officer | Aug 2014 |
| Peter Traynor | Executive officer | Jul 2013 |
| Judith M. Huber | Executive officer | Jun 2012 |
| Judy Huber | Executive officer | Aug 2010 |
| Phil Licari | Executive officer | Jan 2010 |
| Aditya Puri | Director | Aug 2014 |
| Brad Langdale | Director | Aug 2014 |
| Colm Christopher Lanigan | Director | Aug 2014 |
| Frank Muhlenbeck | Director | Aug 2014 |
| Ken Fallon | Director | Aug 2014 |
| Laurent Souviron | Director | Aug 2014 |
| Michael Milligan | Director | Aug 2014 |
| Philipp Lang | Director | Aug 2014 |
| Aditya M. Puri | Director | Jun 2012 |
| Brad M. Langdale | Director | Jun 2012 |
| Frank M. Muhlenbeck | Director | Jun 2012 |
| Ken M. Fallon | Director | Jun 2012 |
| Laurent M. Souviron | Director | Jun 2012 |
| Michael M. Milligan | Director | Jun 2012 |
| Anselm Leung | Director | Aug 2010 |